Ace Report Cover
Annual infusion of zoledronic acid reduces days of back pain, disability, and bed rest
Reprints
Cite This
Reprints
Cite This
AceReport Image
Spine
Annual infusion of zoledronic acid reduces days of back pain, disability, and bed rest
Verified
This report has been verified by one or more authors of the original publication.
J Bone Miner Res. 2011 May;26(5):984-92. doi: 10.1002/jbmr.292

In a secondary prespecified analysis, 7736 postmenopausal women with osteoporosis were examined to evaluate the effect of once-yearly zoledronic acid on improving back pain and disability. Patients received either a single 15 minute intravenous fusion of zoledronic acid (5 mg) or placebo at baseline, 12 months, and 24 months. The assessment at 36 months indicated that zoledronic acid significantly reduced the number of days with back pain when compared to placebo. Additionally, zoledronic acid reduced the number of days of limited activity due to back pain and limited activity and bed rest after a fracture.

Unlock the full article

Get unlimited access to OrthoEvidence with a free trial
Start Trial

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or continue reading this full article
Register Now
AskOE
Search
Close Search Window
Welcome Back!
Forgot Password?
Create an Account

Account will be affiliated with


OR
Forgot Password?

OR
Check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see the email, please check your spam or junk folder.

For further assistance, contact our support team.

Cite this Ace Report

OrthoEvidence. Annual infusion of zoledronic acid reduces days of back pain, disability, and bed rest. ACE Report. 2014;4(3):9. Available from: https://myorthoevidence.com/AceReport/Report/

Copy Citation
Share this Ace Report